Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Dent Assoc ; 147(4): 278-87, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26822100

ABSTRACT

BACKGROUND: The authors compared the local anesthetic efficacy and safety of an intranasally administered formulation of tetracaine and oxymetazoline (K305) with placebo in adult participants undergoing single dental restorative procedures in teeth nos. 4 through 13. METHODS: The authors screened and allocated 150 participants in a double-masked, randomized fashion to either K305 or placebo nasal spray. The authors delivered the study drug as two 0.2-milliliter sprays separated by 4 minutes inside the nostril on the side ipsilateral to the tooth being treated. The authors administered a third 0.2-mL spray, if necessary, and administered 4% articaine with 1:200,000 epinephrine by means of injection if anesthesia was inadequate. Safety evaluations included participant reports of adverse events, vital signs, and alcohol sniff tests during the 2-hour study period and at a 1-day follow-up visit. The primary efficacy end point was anesthetic success defined as the completion of the dental procedure without the need for rescue injectable local anesthetic. The authors evaluated differences in success rates observed between K305 and placebo by using a 1-sided Fisher exact test. RESULTS: The overall success rates were 88.0% (95% confidence interval, 80.0-93.6) and 28% (95% confidence interval, 16.2-42.5) for K305 and placebo, respectively (P < .0001). The most frequent adverse effects in the K305 group were rhinorrhea (57.0%) and nasal congestion (26.0%). No serious adverse events occurred during this study. CONCLUSIONS: K305 was effective and well tolerated during restorative procedures in adult participants. PRACTICAL IMPLICATIONS: K305 provides a needleless alternative for obtaining maxillary pulpal anesthesia on premolars, canines, and incisors.


Subject(s)
Anesthesia, Dental/methods , Anesthetics, Local/therapeutic use , Nasal Decongestants/therapeutic use , Oxymetazoline/therapeutic use , Tetracaine/therapeutic use , Administration, Intranasal , Adult , Anesthesia, Dental/adverse effects , Anesthetics, Local/administration & dosage , Anesthetics, Local/adverse effects , Double-Blind Method , Drug Combinations , Female , Humans , Male , Maxilla , Nasal Decongestants/administration & dosage , Nasal Decongestants/adverse effects , Oxymetazoline/administration & dosage , Oxymetazoline/adverse effects , Tetracaine/administration & dosage , Tetracaine/adverse effects , Tooth/innervation
2.
Dent Assist ; 80(4): 14-6, 18-20, 22-3 passim; quiz 29-31, 2011.
Article in English | MEDLINE | ID: mdl-21922984

ABSTRACT

The consumption of soda pop in the United States continues to increase in alarming proportions with consequent drastic effects on the dentition of many people. Patients should be asked about how much soda pop they ingest. Parents should be counseled on the effects of soda pop demineralization and begin to limit the amounts given to children at home and in schools. The dental team has the expertise and training to intervene with diet counseling, home care instructions and professionally applied fluoride to decrease the potential ravages of soda pop.


Subject(s)
Carbonated Beverages/adverse effects , Tooth Demineralization/etiology , Acids , Carbonated Beverages/classification , Cariostatic Agents/administration & dosage , Cariostatic Agents/therapeutic use , Dental Caries/etiology , Feeding Behavior , Fluorides/administration & dosage , Fluorides/therapeutic use , Humans , Hydrogen-Ion Concentration , Tooth Erosion/etiology , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...